UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Crizotinib-induced fatal fulminant liver failure

Lung cancer (Amsterdam, Netherlands), 2016-03, Vol.93, p.17-19

2016

Link zum Volltext

Verfügbarkeit prüfen

Fixed Dosing of Monoclonal Antibodies in Oncology

The oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1212-1221

2017

Link zum Volltext

Verfügbarkeit prüfen

Apical ABC Transporters and Cancer Chemotherapeutic Drug Disposition

ABC Transporters and Cancer, 2015, Vol.125, p.1-41

2015

Link zum Volltext

Verfügbarkeit prüfen

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

International journal of cancer, 2013-05, Vol.132 (10), p.2439-2447

2013

Link zum Volltext

Verfügbarkeit prüfen

Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review

Theranostics, 2022-01, Vol.12 (18), p.7804-7820

2022

Link zum Volltext

Verfügbarkeit prüfen

Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

International journal of cancer, 2016-02, Vol.138 (3), p.758-769

2016

Link zum Volltext

Verfügbarkeit prüfen

Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology

Pharmacology research & perspectives, 2021-04, Vol.9 (2), p.e00757-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA

EJNMMI radiopharmacy and chemistry, 2022-11, Vol.7 (1), p.29-29, Article 29

2022

Link zum Volltext

Verfügbarkeit prüfen

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]

Clinical pharmacology: advances and applications, 2020-01, Vol.12, p.177-178

2020

Link zum Volltext

Verfügbarkeit prüfen

No relation between docetaxel administration route and high‐grade diarrhea incidence

Pharmacology research & perspectives, 2020-08, Vol.8 (4), p.e00633-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Robot-assisted Prostate-specific Membrane Antigen–radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study

European urology, 2022-07, Vol.82 (1), p.97-105

2022

Link zum Volltext

Verfügbarkeit prüfen

Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab

The lancet oncology, 2022-12, Vol.23 (12), p.e552-e561

2022

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68 Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer

Journal of Nuclear Medicine, 2023-01, Vol.64 (1), p.63-68

2023

Link zum Volltext

Verfügbarkeit prüfen

99mTcPSMA‐radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE‐II trial

BJU international, 2024-07, Vol.134 (1), p.81-88

2024

Link zum Volltext

Verfügbarkeit prüfen

The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE

European journal of nuclear medicine and molecular imaging, 2023-04, Vol.50 (5), p.1434-1441

2023

Link zum Volltext

Verfügbarkeit prüfen

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel

International journal of cancer, 2015-01, Vol.136 (1), p.225-233

2015

Link zum Volltext

Verfügbarkeit prüfen

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course

PloS one, 2021-11, Vol.16 (11), p.e0260073-e0260073

2021

Link zum Volltext

Verfügbarkeit prüfen

A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute

International journal of clinical pharmacy, 2021-02, Vol.43 (1), p.181-190

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours

Cancer chemotherapy and pharmacology, 2021-06, Vol.87 (6), p.855-869

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply to Xiangyang Yao, Chen Duan, Bo Li, Xiaoliang Wu and Hua Xu’s Letter to the Editor Re: Hilda A. de Barros, Matthias N. van Oosterom, Maarten L. Donswijk, et al. Robot-assisted Prostate-specific Membrane Antigen–radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study. Eur Urol 2022;82:97–105

European urology, 2023-01, Vol.83 (1), p.e13-e14

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir

Clinical cancer research, 2019-09, Vol.25 (18), p.5466-5474

2019

Link zum Volltext

Verfügbarkeit prüfen

Extravasation After [ 177 Lu]Lu-HA-DOTATATE Therapy

Clinical nuclear medicine, 2024-05, Vol.49 (5), p.454

2024

Link zum Volltext

Verfügbarkeit prüfen

99m TcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial

BJU international, 2024-07, Vol.134 (1), p.81-88

2024

Link zum Volltext

Verfügbarkeit prüfen

A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir

European journal of cancer (1990), 2017-11, Vol.86, p.217-225

2017

Link zum Volltext

Verfügbarkeit prüfen

Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling

EJNMMI research, 2023-06, Vol.13 (1), p.60-60, Article 60

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(26)
Pharmacology & Pharmacy
(19)
Oncology
(18)
Medicine
(14)
Medicine & Public Health
(13)
Pharmacokinetics
(12)
Tumors
(12)
Male
(11)
Cancer
(10)
Nuclear Medicine
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Animals
(8)
Docetaxel
(8)
Drug Dosages
(8)
Female
(8)
Imaging
(8)
Prostate Cancer
(8)
Radiology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Crizotinib-induced fatal fulminant liver failure

Fixed Dosing of Monoclonal Antibodies in Oncology

Apical ABC Transporters and Cancer Chemotherapeutic Drug Disposition

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review

Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]

No relation between docetaxel administration route and high‐grade diarrhea incidence

Robot-assisted Prostate-specific Membrane Antigen–radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study

Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab

The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68 Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer

99mTcPSMA‐radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE‐II trial

The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course

A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute

Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours

A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir

Extravasation After [ 177 Lu]Lu-HA-DOTATATE Therapy

99m TcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial

A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir

Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling

Suchergebnisse filtern